Vacunación antigripal en España en tiempos de la COVID-19: resultados de un estudio en farmacia comunitaria
Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study
Hiperpotasemia crónica: Impacto asistencial y económico en España
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Strategic reflection on funding and access to rare disease therapies in Spain
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
newsRARE Vol. 6 Nº 2. Terapias avanzadas y EERR: elementos esenciales para su acceso al mercado
